Exam 2 Review

12345678910111213141516171819202122232425262728293031323334353637
Across
  1. 3. Type of risk an ACO may take on which involves penalties as well as rewards.
  2. 4. Medicare's "Medical Insurance" component, which covers physician services and is financed by premiums and general revenues.
  3. 5. The term for how Original Medicare measures the use of hospital services; it begins on admission and ends after 60 consecutive days without inpatient care.
  4. 10. The health reform measure which focused on all components of the Iron Triangle of Health. (acronym)
  5. 11. The fraudulent practice of documenting irrelevant conditions to make a patient seem more complex for a higher DRG payment.
  6. 13. A continually updated list of medications and related products supported by current evidence-based medicine.
  7. 16. A type of health system that has a diverse network of facilities and providers under one umbrella. (acronym)
  8. 18. A restriction that indicates additional clinical information is needed before a plan will make a decision on covering a drug.
  9. 21. The outpatient prescription drug benefit component of Medicare, established in 2003.
  10. 23. A federal drug pricing program that allows qualifying clinics and hospitals treating low-income patients to buy outpatient drugs at a steep discount.
  11. 24. The most severe type of drug recall, used when a product could cause serious health problems or death.
  12. 26. The maximum ingredient cost that will be paid for a drug, forcing the pharmacy to find the least expensive generic. (acronym)
  13. 27. The role the Government has when creating and enacting health policy.
  14. 28. A joint federal-state, income-based welfare program for selected low-income populations.
  15. 30. An organization of providers (doctors, hospitals, etc.) who agree to take responsibility for the cost and quality of care for a large patient population.
  16. 31. The DHHS agency that oversees health systems and outcomes research.
  17. 32. The DHHS agency responsible for biomedical and health research and a major source of research funding. (acronym)
  18. 34. Medicare's "Hospital Insurance" component, which is financed by payroll taxes.
  19. 35. The Inflation Reduction Act, capped out of pocket spending for this product.
  20. 36. Branch of Government that includes members of Congress.
  21. 37. A reimbursement model that incorporates value-based payments, moving away from pure fee-for-service.
Down
  1. 1. The practice of persuading government branches to vote or act in ways that protect certain interests.
  2. 2. The formula used to determine the federal contribution to each State's Medicaid spending, based on average per capita income. (acronym)
  3. 6. The 2022 law that allows Medicare to negotiate drug prices and requires inflation rebates. (acronym)
  4. 7. Used in the physician payment system to identify the cost components linked to procedures.
  5. 8. A coding system used to classify patient complexity and determine prospective payment for inpatient hospital stays. (acronym)
  6. 9. The 2015 law that created new payment models for physicians, including the Merit-based Incentive Payment System. (acronym)
  7. 12. A mechanism that allows states to test new approaches and operate their Medicaid programs outside of normal federal rules.
  8. 14. The three components of the "Iron Triangle of Politics" are Interest Groups, Bureaucracy and __________.
  9. 15. A federal social insurance program primarily for people aged 65 or older and those with specific disabilities.
  10. 17. A review of prescribing, dispensing, and patient use of drugs which can be prospective (at time of dispensing) or retrospective. (acronym)
  11. 18. The Medicare Advantage program, which allows beneficiaries to enroll in private insurance plans as an alternative to Original Medicare.
  12. 19. The ACA provision that required citizens to have health insurance or pay a penalty.
  13. 20. The "list price" of a drug as determined by the manufacturer. (acronym)
  14. 21. An intermediary contracted by insurance companies to manage prescription claims, formularies, and negotiate rebates. (acronym)
  15. 22. One of the categories of APMs which identifies how reimbursements are made.
  16. 24. The coding system for clinician procedures and services.
  17. 25. In what phase of drug development and approval does post marketing monitoring occur?
  18. 29. When a physician agrees to accept the Medicare-approved amount as full payment for a service.
  19. 33. A formulary restriction that requires a patient to try a less costly medication before the prescribed one will be covered.